期刊文献+

老年耐多药肺结核临床特征及转归分析 被引量:44

A cohort study on the outcome of multidrug.resistant tuberculosis in elderly patients
原文传递
导出
摘要 目的探讨老年耐多药肺结核的临床特征及其转归。方法采用回顾性研究方法,收集上海市肺科医院2007年1月至2010年1月收治的139例耐多药肺结核患者,其中65岁以上老年患者59例(老年组),18—64岁中青年患者80例(中青年组)。记录2组患者的一般临床资料及临床疗效转归、不良反应等。两组间比较采用)(。检验。结果老年组的临床症状除气促明显外,与中青年组没有明显差别。老年组中复治患者(96.6%,57/59)显著多于中青年组(86.3%,69/80),差异有统计学意义(x2=4.299,P〈0.05),老年组的病灶广泛,波及5—6个肺野的患者(57.6%,34/59)显著多于中青年组(22.5%,18/80),治愈率(28.8%,17/59)显著低于中青年组(51.3%,41/80),病死率(17.0%,10/59)显著多于中青年组(3.4%,3/80),差异均有统计学意义(x2值为6.837—17.894,均P〈0.01)。老年组肝、肾功能损伤发生率分别为23.7%(14/59)和10.2%(6/59),显著高于中青年组的10.O%(8/80)和1.3%(1/80),差异均有统计学意义(x2值分别为4.804和5.649,均P〈0.05)。结论老年耐多药肺结核患者的病灶广泛,复治病例较多,不良反应发生率较高,临床治愈率较低,病死率较高。 Objective To investigate the clinical curative effect and outcomes of muhidrug-resistant tuberculosis (MDR-TB) in elderly patients. Methods Fifty-nine elderly patients with MDR-TB were enrolled from Shanghai Pulmonary Hospital from January 2007 to January 2010, and 80 younger patients with MDR-TB during the same period served as the control group. Clinical characteristics, outcomes and adverse effects of treatment were reviewed, and the data of the 2 groups were compared using cohort analysis. Comparisons of categorical variables were performed using the Pearson Chi-square tests, and differences between groups were compared by Fisher' s exact test. Results Compared with those of the younger patients, the clinical symptoms of the elderly patients showed no significant differences except shortness of breath. The proportion of retreated patients in the elderly patients (96. 6% , 57/59) was significantly higher than that in the younger group (86. 3%, 69/80) (X2 =4. 299, P 〈0.05). The proportion of the patients with lesions involving 5 - 6 lung fields in the elderly group was 57. 6% ( 34/59 ), higher than that in the younger group (22. 5%, 18/80) (X2 = 17. 894, P 〈 0.01). The treatment success rate in the elderly MDR-TB group was 28.2% (17/59), lower than that in the younger group (51.3%, 41/80) (X2 = 7. 029, P 〈0. 01 ). The death rate in the elderly group was 17. 0% ( 10/59), significantly higher than that in the younger group (3.4% , 3/80) ( ~5 = 6. 837 - 17. 894, P 〈 0. 05). The incidence of liver injury in the elderly group was higher than that in the younger group (23.7% , 14/59 vs 10.0% , 8/80,X2 =4. 804, P〈0.05), and so was that of kidney dysfunction (10.2%, 6/59 vs 1.3%, 1/80, X2 =5.649, P 〈 0. 05 ). Conclusions In elderly patients with MDR-TB, the pulmonary lesions were extensive, the number of retreated eases was higher, and the incidence of adverse drug reactions was also higher. The treatment success rate was lower while the mortality rate was higher for elderly patients with MDR-TB.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2014年第3期188-191,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 结核 老年人 结核 抗多种药物性 Tuberculosis, pulmonary Aged Tuberculosis, multidrug-resistant
  • 相关文献

参考文献16

  • 1中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007~2008年)[M].北京:人民卫生出版社,2010.5-61.
  • 2Yamaguchi Y, Kawabe Y, Nagayama N, et al. A study on the clinical features of pulmonary tuberculosis in elderly patients [ J ]. Kekkaku, 2001,76: 447-454.
  • 3Das SK, Mukherjee RS, Ghosh IN, et al. A study of pulmonary tuberculosis in the elderly[J]. J Indian Med Assoc, 2007, 105: 432, 436, 438-439.
  • 4Wodd Health Organization. Global tuberculosis report 2012[ R]. Geneva: WHO, 2012.
  • 5Kwon YS, Chi SY, Oh 1J, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a ease eontrol study[J]. BMCInfect Dis, 2013, 13: 121.
  • 6World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008 [ R]. Geneva: WHO, 2008.
  • 7肖和平.耐药结核病化学治疗指南(2009)[J].中华结核和呼吸杂志,2010,33(7):485-497. 被引量:172
  • 8World Health Organization. Towards universal access to diagnosis and treatment of muhidrug-resistant and extensively drug-resistant tuberculosis by 2015 : WHO progress report 2011 [ R]. Geneva: WHO, 2011.
  • 9肖和平.中国耐药结核病的流行现状与治疗对策[J].中华结核和呼吸杂志,2010,33(7):481-482. 被引量:45
  • 10Faustini A, Hall AJ, Perucci resistant tuberculosis in Europe 2006, 61 : 158-163.

二级参考文献11

  • 1端木宏谨.耐药结核病的流行和监测[J].中华结核和呼吸杂志,2006,29(8):509-511. 被引量:38
  • 2肖和平.耐多药结核病化疗药物的选择与方案的制定[J].中华结核和呼吸杂志,2006,29(8):517-519. 被引量:32
  • 3World Health Organization.Global tuberculoiss control-epidemiology,strategy,financing.Genera:WHO,2009:34-53.
  • 4Nitta AT,Davidson PT,de Koning ML,et al.Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors.JAMA,1996,276:1980-1983.
  • 5World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis:emergency update 2008.Geneva:WHO,2008:50-197.
  • 6Sullivan EA,Kreiswirth BN,Palumbo L,et al.Emergence of fluoroquinolone-resistant tuberculosis in New York City.Lancet,1995,345:1148-1150.
  • 7Nathanson E,Lambregts-van Weezenbeek C,Rich ML,et al.Multidrug-resistant tuberculosis management in resource-limited settings.Emerg Infect Dis,2006,12:1389-1397.
  • 8World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis:emergency update 2008.Geneva:WHO,2008:50-197.
  • 9肖和平.耐药结核病化学治疗指南(2009)[J].中华结核和呼吸杂志,2010,33(7):485-497. 被引量:172
  • 10全国结核病流行病学抽样调查技术指导组.第四次全国结核病流行病学抽样调查报告[J].中华结核和呼吸杂志,2002,25(1):3-7. 被引量:1185

共引文献209

同被引文献591

引证文献44

二级引证文献346

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部